Showing results (721-730 of 1,211) with videos related to

Sort By:
Pageof 122
Plos One|March 27, 2020
Onset of brain injury in infants with prenatally diagnosed congenital heart diseaseMirthe J Mebius, Catherina M Bilardo, Martin C J Kneyber, et al.
Heart (British Cardiac Society)|September 8, 2019
Pulmonary artery size is associated with functional clinical status in the Fontan circulationFloris-Jan S Ridderbos, Bregje E Bonenkamp, Sophie L Meyer, et al.
European Journal of Clinical Investigation|August 22, 2006
First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertensionK Lunze, N Gilbert, S Mebus, et al.
Annals of Surgical Oncology|June 27, 2013
Malignant peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is GLUT1 expression a major prognostic factor? A preliminary studyJ Hommell-Fontaine, S Isaac, G Passot, et al.
Cardiology in the Young|December 21, 2016
Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registryTilman Humpl, Rolf M F Berger, Eric D Austin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantationJ L Garnier, F Berger, H Betuel, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 1, 2021
Circulatory efficiency in patients with severe aortic valve stenosis before and after aortic valve replacementS Nordmeyer, C B Lee, L Goubergrits, et al.
Endocrine-Related Cancer|January 22, 2024
Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasmsDarren Cowzer, Ronak H Shah, Joanne F Chou, et al.
Pulmonary Circulation|July 14, 2022
Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activationEmmanouil Mavrogiannis, Quint A J Hagdorn, Venetia Bazioti, et al.
Pharmacogenomics|June 23, 2017
Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics studyAizati N A Daud, Jorieke E H Bergman, Wilhelmina S Kerstjens-Frederikse, et al.
Pageof 122